Physician profile
Daniel Obermark
NPI 1194709220
$1,247.88
in general payments reported to CMS, 2019-2025
10 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.59 · 2020: $131 · 2021: $102 · 2022: $369 · 2023: $36.78 · 2024: $303 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $267.60 | 2024-2025 | Xiidra, Miebo |
| Carl Zeiss Meditec, INC. | $239.94 | 2022 | |
| Abbvie INC. | $231.67 | 2024-2025 | |
| Alcon Vision LLC | $189.46 | 2019-2025 | Total30, Precision7 |
| Novartis Pharmaceuticals Corporation | $144.21 | 2019-2020 | |
| Allergan, INC. | $69.41 | 2019-2022 | |
| Oyster Point Pharma, INC. | $43.60 | 2022 | |
| Abb Con-Cise Optical Group LLC | $26.24 | 2019 | |
| Lkc Technologies, INC. | $20.32 | 2024 | |
| Sight Sciences, INC. | $15.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Obermark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.